Table 3. The proportion of participants who accessed each FAQ and stayed long enough to have read each level of information.
|
Level one*
|
Level two*
|
Level three*
|
||||
|---|---|---|---|---|---|---|
| Purpose of the study | 17/44 | 39% | 3/44 | 7% | 1/44 | 2% |
| Have to take part | 6/44 | 14% | 0/44 | 0% | 0/44 | 0% |
| Why been chosen | 18/44 | 41% | 4/44 | 9% | 1/44 | 2% |
| Expenses | 22/44 | 50% | 5/44 | 11% | 1/44 | 2% |
| What will happen | 13/44 | 30% | 0/44 | 0% | 0/44 | 0% |
| Risks | 22/44 | 50% | 7/44 | 16% | 2/44 | 5% |
| Benefits | 20/44 | 46% | 3/44 | 7% | 0/44 | 0% |
| Problems | 16/44 | 36% | 1/44 | 2% | 0/44 | 0% |
| Confidentiality | 10/44 | 23% | 1/44 | 2% | 0/44 | 0% |
| Don’t want to carry on | 6/44 | 14% | 0/44 | 0% | 0/44 | 0% |
| GP | 14/44 | 32% | 3/44 | 7% | 1/44 | 2% |
| Samples | 15/44 | 34% | n/a** | n/a** | ||
| Genetic tests | 10/44 | 23% | n/a** | n/a** | ||
| Results | 11/44 | 25% | 1/44 | 2% | 1/44 | 2% |
| Organising and funding | 10/44 | 23% | 3/44 | 7% | 2/44 | 5% |
| Reviewed study | 11/44 | 26% | 2/44 | 5% | 2/44 | 5% |
| Further info and contact | 4/44 | 9% | n/a** | n/a** | ||
| Accessing any information type | 26/44 | 59% | 8/44 | 18% | 4/44 | 9% |
*
Participants who did not access level 1 could not access any of the later levels and participants who accessed levels 2 and 3 must have accessed the previous levels to do so and are therefore included in the figures for the previous level.
**
n/a means there was no information available under that level